US Stock MarketDetailed Quotes

XRTX XORTX Therapeutics

Watchlist
  • 1.0101
  • +0.0601+6.33%
Close Mar 14 16:00 ET
3.42MMarket Cap8.42P/E (TTM)

XORTX Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-37.22%874.75K
-15.21%1.49M
-42.92%1.09M
-41.25%6.05M
-63.02%983.67K
-33.75%1.39M
-33.56%1.76M
-33.68%1.91M
253.56%10.29M
102.94%2.66M
Selling and administrative expenses
7.16%546.63K
13.24%817.91K
0.33%512.15K
-7.13%2.23M
-4.86%484.85K
5.75%510.11K
-0.69%722.3K
-24.89%510.46K
48.43%2.4M
-30.15%509.6K
-General and administrative expense
7.16%546.63K
13.24%817.91K
0.33%512.15K
-7.13%2.23M
-4.86%484.85K
5.75%510.11K
-0.69%722.3K
-24.89%510.46K
48.43%2.4M
-30.15%509.6K
Research and development costs
-93.90%34.74K
-89.87%67.68K
-92.97%73.64K
-64.23%2.42M
-92.95%134.13K
-61.32%569.71K
-54.19%667.91K
-45.69%1.05M
897.94%6.76M
449.11%1.9M
Depreciation amortization depletion
57.58%25.95K
3.21%33.05K
-51.93%32.13K
140.25%139.69K
7.99%24.36K
-25.34%16.47K
228.21%32.02K
1,670.31%66.85K
307.58%58.15K
469.33%22.56K
-Depreciation and amortization
57.58%25.95K
3.21%33.05K
-51.93%32.13K
140.25%139.69K
7.99%24.36K
-25.34%16.47K
228.21%32.02K
1,670.31%66.85K
307.58%58.15K
469.33%22.56K
Other operating expenses
-9.96%267.43K
69.40%575.05K
66.30%470.7K
17.55%1.26M
51.59%340.34K
135.93%297.02K
-25.63%339.47K
6.84%283.03K
77.87%1.07M
-2.63%224.51K
Operating profit
37.22%-874.75K
15.21%-1.49M
42.92%-1.09M
41.25%-6.05M
63.02%-983.67K
33.75%-1.39M
33.56%-1.76M
33.68%-1.91M
-253.56%-10.29M
-102.94%-2.66M
Net non-operating interest income expense
-54.38%29.02K
-50.96%35.95K
-52.69%31.6K
144.76%253.54K
-7.26%49.82K
79.40%63.61K
523.19%73.31K
2,421.78%66.8K
2,427.32%103.59K
4,018.84%53.72K
Non-operating interest income
-54.38%29.02K
-50.96%35.95K
-52.69%31.6K
----
----
79.40%63.61K
523.19%73.31K
2,421.78%66.8K
----
----
Total other finance cost
----
----
----
-144.76%-253.54K
----
----
----
----
-2,427.32%-103.59K
----
Other net income (expense)
7,153.30%258.72K
46,688.55%1.63M
-23,298.79%-1.96M
47.25%3.63M
13,367.34%3.63M
-100.42%-3.67K
-100.25%-3.49K
-95.01%8.46K
84.77%2.47M
-99.67%26.98K
Gain on sale of security
7,153.30%258.72K
46,688.55%1.63M
-23,298.79%-1.96M
7.06%3.63M
281.05%3.63M
-100.42%-3.67K
-100.25%-3.49K
-95.01%8.46K
29.37%3.39M
-89.91%953.43K
Special income (charges)
----
----
----
--0
----
----
----
----
28.08%-926.46K
----
-Less：Restructuring and merger&acquisition
----
----
----
--0
----
----
----
----
-28.08%926.46K
----
Income before tax
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
Income tax
Net income
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
Net income continuous Operations
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
Minority interest income
Net income attributable to the parent company
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
Basic earnings per share
70.15%-0.2
107.06%0.06
-30.53%-1.24
79.12%-1.09
182.51%1.37
19.27%-0.67
-4.94%-0.85
49.74%-0.95
-262.50%-5.22
-123.87%-1.6604
Diluted earnings per share
70.15%-0.2
107.06%0.06
-30.53%-1.24
79.12%-1.09
182.51%1.37
19.27%-0.67
-4.94%-0.85
49.74%-0.95
-262.50%-5.22
-123.87%-1.6604
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -37.22%874.75K-15.21%1.49M-42.92%1.09M-41.25%6.05M-63.02%983.67K-33.75%1.39M-33.56%1.76M-33.68%1.91M253.56%10.29M102.94%2.66M
Selling and administrative expenses 7.16%546.63K13.24%817.91K0.33%512.15K-7.13%2.23M-4.86%484.85K5.75%510.11K-0.69%722.3K-24.89%510.46K48.43%2.4M-30.15%509.6K
-General and administrative expense 7.16%546.63K13.24%817.91K0.33%512.15K-7.13%2.23M-4.86%484.85K5.75%510.11K-0.69%722.3K-24.89%510.46K48.43%2.4M-30.15%509.6K
Research and development costs -93.90%34.74K-89.87%67.68K-92.97%73.64K-64.23%2.42M-92.95%134.13K-61.32%569.71K-54.19%667.91K-45.69%1.05M897.94%6.76M449.11%1.9M
Depreciation amortization depletion 57.58%25.95K3.21%33.05K-51.93%32.13K140.25%139.69K7.99%24.36K-25.34%16.47K228.21%32.02K1,670.31%66.85K307.58%58.15K469.33%22.56K
-Depreciation and amortization 57.58%25.95K3.21%33.05K-51.93%32.13K140.25%139.69K7.99%24.36K-25.34%16.47K228.21%32.02K1,670.31%66.85K307.58%58.15K469.33%22.56K
Other operating expenses -9.96%267.43K69.40%575.05K66.30%470.7K17.55%1.26M51.59%340.34K135.93%297.02K-25.63%339.47K6.84%283.03K77.87%1.07M-2.63%224.51K
Operating profit 37.22%-874.75K15.21%-1.49M42.92%-1.09M41.25%-6.05M63.02%-983.67K33.75%-1.39M33.56%-1.76M33.68%-1.91M-253.56%-10.29M-102.94%-2.66M
Net non-operating interest income expense -54.38%29.02K-50.96%35.95K-52.69%31.6K144.76%253.54K-7.26%49.82K79.40%63.61K523.19%73.31K2,421.78%66.8K2,427.32%103.59K4,018.84%53.72K
Non-operating interest income -54.38%29.02K-50.96%35.95K-52.69%31.6K--------79.40%63.61K523.19%73.31K2,421.78%66.8K--------
Total other finance cost -------------144.76%-253.54K-----------------2,427.32%-103.59K----
Other net income (expense) 7,153.30%258.72K46,688.55%1.63M-23,298.79%-1.96M47.25%3.63M13,367.34%3.63M-100.42%-3.67K-100.25%-3.49K-95.01%8.46K84.77%2.47M-99.67%26.98K
Gain on sale of security 7,153.30%258.72K46,688.55%1.63M-23,298.79%-1.96M7.06%3.63M281.05%3.63M-100.42%-3.67K-100.25%-3.49K-95.01%8.46K29.37%3.39M-89.91%953.43K
Special income (charges) --------------0----------------28.08%-926.46K----
-Less：Restructuring and merger&acquisition --------------0-----------------28.08%926.46K----
Income before tax 55.98%-587.01K110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M
Income tax
Net income 55.98%-587.01K110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M
Net income continuous Operations 55.98%-587.01K110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M
Minority interest income
Net income attributable to the parent company 55.98%-587.01K110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 55.98%-587.01K110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M
Basic earnings per share 70.15%-0.2107.06%0.06-30.53%-1.2479.12%-1.09182.51%1.3719.27%-0.67-4.94%-0.8549.74%-0.95-262.50%-5.22-123.87%-1.6604
Diluted earnings per share 70.15%-0.2107.06%0.06-30.53%-1.2479.12%-1.09182.51%1.3719.27%-0.67-4.94%-0.8549.74%-0.95-262.50%-5.22-123.87%-1.6604
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
New Fortress Energy
NFE
9.260
Teradata Corp
TDC
22.690
Enerpac Tool
EPAC
43.960
4
DexCom
DXCM
70.690
5
Precision Drilling
PDS
44.680
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call